How is transfusion-related acute lung injury (TRALI) managed?
文章推薦指數: 80 %
Transfusion-related acute lung injury (TRALI) is managed as follows: Immediately discontinue the transfusion while preserving venous access. ForYou News&Perspective Drugs&Diseases CME&Education Academy Video DecisionPoint Specialty: Multispecialty Allergy&Immunology Anesthesiology BusinessofMedicine Cardiology CriticalCare Dermatology Diabetes&Endocrinology EmergencyMedicine FamilyMedicine Gastroenterology GeneralSurgery Hematology-Oncology HIV/AIDS HospitalMedicine InfectiousDiseases InternalMedicine Multispecialty Nephrology Neurology Ob/Gyn&Women'sHealth Oncology Ophthalmology Orthopedics Pathology&LabMedicine Pediatrics PlasticSurgery Psychiatry PublicHealth PulmonaryMedicine Radiology Rheumatology Transplantation Urology MedicalStudents Nurses Pharmacists Residents TodayonMedscape Edition: English Medscape English Deutsch Español Français Português UKNew Univadis LogIn SignUpIt'sFree! EnglishEdition Medscape English Deutsch Español Français Português UKNew Univadis X UnivadisfromMedscape Register LogIn NoResults NoResults Monday,May16,2022 ForYou News&Perspective Drugs&Diseases CME&Education Academy Video DecisionPoint close PleaseconfirmthatyouwouldliketologoutofMedscape. Ifyoulogout,youwillberequiredtoenteryourusernameandpasswordthenexttimeyouvisit. Logout Cancel https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly93d3cubWVkc2NhcGUuY29tL2Fuc3dlcnMvMjA2ODg1LTEwODY0My9ob3ctaXMtdHJhbnNmdXNpb24tcmVsYXRlZC1hY3V0ZS1sdW5nLWluanVyeS10cmFsaS1tYW5hZ2Vk processing.... Drugs&Diseases > Hematology > TransfusionReactionsQ&A Howistransfusion-relatedacutelunginjury(TRALI)managed? Updated:Jan12,2021 Author:SGeraldSandler,MD,FCAP,FACP;ChiefEditor:EmmanuelCBesa,MD more... References Share Email Print Feedback Close Facebook Twitter LinkedIn WhatsApp Answer Transfusion-relatedacutelunginjury(TRALI)ismanagedasfollows: Immediatelydiscontinuethetransfusionwhilepreservingvenousaccess. Patientswithmildepisodesshouldrespondtooxygenadministeredbynasalcatheterormask.Ifshortnessofbreathpersistsafteroxygenadministration,transferthepatienttoanintensivecaresettingwheremechanicalventilationcanbeemployed. Intheabsenceofsignsofacutevolumeoverloadorcardiogenicpulmonaryedema,diureticsarenotindicated. Noevidenceexiststhatcorticosteroidsorantihistaminesarebeneficial. Treatcomplicationswithspecificsupportivemeasures. ReadMore Didthisansweryourquestion? Yes No Additionalfeedback?(Optional) Submit Thankyouforyourfeedback! RelatedQuestions: References FrazierSK,HigginsJ,BugajskiA,JonesAR,BrownMR.AdverseReactionstoTransfusionofBloodProductsandBestPracticesforPrevention.CritCareNursClinNorthAm.2017Sep.29(3):271-290.[Medline]. YehSP,ChangCW,ChenJC,YehWC,ChenPC,ChuangSJ,etal.Awell-designedonlinetransfusionreactionreportingsystemimprovestheestimationoftransfusionreactionincidenceandqualityofcareintransfusionpractice.AmJClinPathol.2011Dec.136(6):842-7.[Medline]. FastmanBR,KaplanHS.Errorsintransfusionmedicine:havewelearnedourlesson?.MtSinaiJMed.2011Nov-Dec.78(6):854-64.[Medline]. SquiresJE.Risksoftransfusion.SouthMedJ.2011Nov.104(11):762-9.[Medline]. HabibiA,Mekontso-DessapA,GuillaudC,MichelM,RazaziK,KhellafM,etal.Delayedhemolytictransfusionreactioninadultsickle-celldisease:presentations,outcomes,andtreatmentsof99referralcenterepisodes.AmJHematol.2016Oct.91(10):989-94.[Medline].[FullText]. deMontalembertM,DumontMD,HeilbronnerC,BrousseV,CharraraO,PellegrinoB,etal.Delayedhemolytictransfusionreactioninchildrenwithsicklecelldisease.Haematologica.2011Jun.96(6):801-7.[Medline].[FullText]. Keller-StanislawskiB,LohmannA,GünayS,HeidenM,FunkMB.TheGermanHaemovigilanceSystem-reportsofseriousadversetransfusionreactionsbetween1997and2007.TransfusMed.2009Aug31.[Medline]. SillimanCC.Thetwo-eventmodeloftransfusion-relatedacutelunginjury.CritCareMed.2006May.34(5suppl):S124-31.[Medline]. SillimanCC,CurtisBR,KopkoPM,etal.DonorantibodiestoHNA-3aimplicatedinTRALIreactionsprimeneutrophilsandcausePMN-mediateddamagetohumanpulmonarymicrovascularendothelialcellsinatwo-eventinvitromodel.Blood.2007Feb15.109(4):1752-5.[Medline].[FullText]. CurtisBR,McFarlandJG.Mechanismsoftransfusion-relatedacutelunginjury(TRALI):anti-leukocyteantibodies.CritCareMed.2006May.34(5suppl):S118-23.[Medline]. SkeateRC,EastlundT.Distinguishingbetweentransfusionrelatedacutelunginjuryandtransfusionassociatedcirculatoryoverload.CurrOpinHematol.2007Nov.14(6):682-7.[Medline]. FadeyiEA,DeLosAngelesMunizM,WayneAS,etal.Thetransfusionofneutrophil-specificantibodiescausesleukopeniaandabroadspectrumofpulmonaryreactions.Transfusion.2007Mar.47(3):545-50.[Medline]. VlaarAP,JuffermansNP.Transfusion-relatedacutelunginjury:aclinicalreview.Lancet.2013Sep14.382(9896):984-94.[Medline]. GajicO,GropperMA,HubmayrRD.Pulmonaryedemaaftertransfusion:howtodifferentiatetransfusion-associatedcirculatoryoverloadfromtransfusion-relatedacutelunginjury.CritCareMed.2006May.34(5suppl):S109-13.[Medline]. NessP,CreerM,RodgersGM,NaoumJJ,RenkensK,VoilsSA,etal.Buildinganimmune-mediatedcoagulopathyconsensus:earlyrecognitionandevaluationtoenhancepost-surgicalpatientsafety.PatientSafSurg.2009May22.3(1):8.[Medline].[FullText]. GarrattyG.Immunehemolyticanemiaassociatedwithnegativeroutineserology.SeminHematol.2005Jul.42(3):156-64.[Medline]. CaponSM,GoldfingerD.Acutehemolytictransfusionreaction,aparadigmofthesystemicinflammatoryresponse:newinsightsintopathophysiologyandtreatment.Transfusion.1995Jun.35(6):513-20.[Medline]. DavenportRD.Theroleofcytokinesinhemolytictransfusionreactions.ImmunolInvest.1995Jan-Feb.24(1-2):319-31.[Medline]. SandlerSG,BerryE,ZiotnickA.Benignhemoglobinuriafollowingtransfusionofaccidentallyfrozenblood.JAMA.1976Jun28.235(26):2850-1.[Medline]. SandlerSG,MalloryD,MalamutD,EckrichR.IgAanaphylactictransfusionreactions.TransfusMedRev.1995Jan.9(1):1-8.[Medline]. SandlerSG,EderAF,GoldmanM,WintersJL.TheentityofimmunoglobulinA-relatedanaphylactictransfusionreactionsisnotevidencebased.Transfusion.2015Jan.55(1):199-204.[Medline]. ShimadaE,OdagiriM,ChaiwongK,etal.DetectionofHpdelamongThais,adeletedalleleofthehaptoglobingenethatcausescongenitalhaptoglobindeficiency.Transfusion.2007Dec.47(12):2315-21.[Medline]. ShimadaE,TadokoroK,WatanabeY,etal.Anaphylactictransfusionreactionsinhaptoglobin-deficientpatientswithIgEandIgGhaptoglobinantibodies.Transfusion.2002Jun.42(6):766-73.[Medline]. ChoiG,SoetersMR,FarkasH,etal.RecombinanthumanC1-inhibitorinthetreatmentofacuteangioedemaattacks.Transfusion.2007Jun.47(6):1028-32.[Medline]. JonesJM,SapianoMRP,SavinkinaAA,HaassKA,BakerML,HenryRA,etal.SlowingdeclineinbloodcollectionandtransfusionintheUnitedStates-2017.Transfusion.2020Mar.60Suppl2:S1-S9.[Medline].[FullText]. SavinkinaAA,HaassKA,SapianoMRP,HenryRA,BergerJJ,BasavarajuSV,etal.Transfusion-associatedadverseeventsandimplementationofbloodsafetymeasures-findingsfromthe2017NationalBloodCollectionandUtilizationSurvey.Transfusion.2020Mar.60Suppl2:S10-S16.[Medline].[FullText]. PopovskyMA,MooreSB.Diagnosticandpathogeneticconsiderationsintransfusion-relatedacutelunginjury.Transfusion.1985Nov-Dec.25(6):573-7.[Medline]. KopkoPM,PopovskyMA,MacKenzieMR,etal.HLAclassIIantibodiesintransfusion-relatedacutelunginjury.Transfusion.2001Oct.41(10):1244-8.[Medline]. WeberJG,WarnerMA,MooreSB.Whatistheincidenceofperioperativetransfusion-relatedacutelunginjury?.Anesthesiology.1995Mar.82(3):789.[Medline]. SillimanCC,BoshkovLK,MehdizadehkashiZ,etal.Transfusion-relatedacutelunginjury:epidemiologyandaprospectiveanalysisofetiologicfactors.Blood.2003Jan15.101(2):454-62.[Medline].[FullText]. BlajchmanMA.Protectingthebloodsupplyfromemergingpathogens:theroleofpathogeninactivation.TransfusClinBiol.2009May.16(2):70-4.[Medline]. [Guideline]CarsonJL,GrossmanBJ,KleinmanS,TinmouthAT,MarquesMB,FungMK,etal.Redbloodcelltransfusion:aclinicalpracticeguidelinefromtheAABB*.AnnInternMed.2012Jul3.157(1):49-58.[Medline].[FullText]. LooneyMR,RoubinianN,GajicO,GropperMA,HubmayrRD,LowellCA,etal.Prospectivestudyontheclinicalcourseandoutcomesintransfusion-relatedacutelunginjury*.CritCareMed.2014Jul.42(7):1676-87.[Medline]. EderAF,KennedyJM,DyBA,etal.Bacterialscreeningofapheresisplateletsandtheresidualriskofseptictransfusionreactions:theAmericanRedCrossexperience(2004-2006).Transfusion.2007Jul.47(7):1134-42.[Medline]. BlajchmanMA,BeckersEA,DickmeissE,etal.Bacterialdetectionofplatelets:currentproblemsandpossibleresolutions.TransfusMedRev.2005Oct.19(4):259-72.[Medline]. BarrettBB,AndersenJW,AndersonKC.Strategiesfortheavoidanceofbacterialcontaminationofbloodcomponents.Transfusion.1993Mar.33(3):228-33.[Medline]. DzieczkowskiJS,BarrettBB,NesterD,etal.Characterizationofreactionsafterexclusivetransfusionofwhitecell-reducedcellularbloodcomponents.Transfusion.1995Jan.35(1):20-5.[Medline]. MenitoveJE,McElligottMC,AsterRH.Febriletransfusionreaction:whatbloodcomponentshouldbegivennext?.VoxSang.1982.42(6):318-21.[Medline]. PinedaAA,TaswellHF.Transfusionreactionsassociatedwithanti-IgAantibodies:reportoffourcasesandreviewoftheliterature.Transfusion.1975Jan-Feb.15(1):10-5.[Medline]. OakleyFD,WoodsM,ArnoldS,YoungPP.Transfusionreactionsinpediatriccomparedwithadultpatients:alookatrate,reactiontype,andassociatedproducts.Transfusion.2015Mar.55(3):563-70.[Medline]. FatalitiesReportedtoFDAFollowingBloodCollectionandTransfusion.U.S.FoodandDrugAdministration.Availableathttps://www.fda.gov/media/136907/download#:~:text=The%20corresponding%20fatalities%20were%2041,inherent%20variations%20in%20reporting%20accuracy..Accessed:January12,2021. RohdeJM,DimcheffDE,BlumbergN,SaintS,LangaKM,KuhnL,etal.Healthcare-associatedinfectionafterredbloodcelltransfusion:asystematicreviewandmeta-analysis.JAMA.2014Apr2.311(13):1317-26.[Medline]. HillyerCD,JosephsonCD,BlajchmanMA,etal.Bacterialcontaminationofbloodcomponents:risks,strategies,andregulation:jointASHandAABBeducationalsessionintransfusionmedicine.HematologyAmSocHematolEducProgram.2003.575-89.[Medline].[FullText]. BeauregardP,BlajchmanMA.Hemolyticandpseudo-hemolytictransfusionreactions:anoverviewofthehemolytictransfusionreactionsandtheclinicalconditionsthatmimicthem.TransfusMedRev.1994Jul.8(3):184-99.[Medline]. YuH,SandlerSG.IgAanaphylactictransfusionreactions.TransfusMedHemother.2003.30:214-20. FarkasH,JakabL,TemesszentandrasiG,etal.Hereditaryangioedema:adecadeofhumanC1-inhibitorconcentratetherapy.JAllergyClinImmunol.2007Oct.120(4):941-7.[Medline]. VichinskyEP,EarlesA,JohnsonRA,etal.Alloimmunizationinsicklecellanemiaandtransfusionofraciallyunmatchedblood.NEnglJMed.1990Jun7.322(23):1617-21.[Medline]. ShariatmadarS,PyrsopoulosNT,VincekV,NotoTA,TzakisAG.Alloimmunizationtoredcellantigensinliverandmultivisceraltransplantpatients.Transplantation.2007Aug27.84(4):527-31.[Medline]. CastroO,SandlerSG,Houston-YuP,RanaS.Predictingtheeffectoftransfusingonlyphenotype-matchedRBCstopatientswithsicklecelldisease:theoreticalandpracticalimplications.Transfusion.2002Jun.42(6):684-90.[Medline]. OrlinaAR,SoslerSD,KoshyM.Problemsofchronictransfusioninsicklecelldisease.JClinApher.1991.6(4):234-40.[Medline]. HabibiA,Mekontso-DessapA,GuillaudC,MichelM,RazaziK,KhellafM,etal.Delayedhemolytictransfusionreactioninadultsickle-celldisease:Presentations,outcomesandtreatmentsof99referralcenterepisodes.AmJHematol.2016Jun27.[Medline]. FongSW,QaqundahBY,TaylorWF.DevelopmentalpatternsofABOisoagglutininsinnormalchildrencorrelatedwiththeeffectsofage,sex,andmaternalisoagglutinins.Transfusion.1974Nov-Dec.14(6):551-9.[Medline]. BaumgartenA,KruchokAH,WeirichF.HighfrequencyofIgGanti-Aand-Bantibodyinoldage.VoxSang.1976.30(4):253-60.[Medline]. HongH,XiaoW,LazarusHM,GoodCE,MaittaRW,JacobsMR.Detectionofseptictransfusionreactionstoplatelettransfusionsbyactiveandpassivesurveillance.Blood.2016Jan28.127(4):496-502.[Medline]. EderAF,DyBA,HerronRM,etal.EffectivereductionofTRALIriskwithplasmacollectedpredominatelyfrommaledonors[abstract].Transfusion.2009.49(supp):45a. PalavecinoE,YomtovianR.Riskandpreventionoftransfusion-relatedsepsis.CurrOpinHematol.2003Nov.10(6):434-9.[Medline]. EzidiegwuCN,LauensteinKJ,RosalesLG,KellyKC,HenryJB.Febrilenonhemolytictransfusionreactions.Managementbypremedicationandcostimplicationsinadultpatients.ArchPatholLabMed.2004Sep.128(9):991-5.[Medline].[FullText]. MekontsoDessapA,PirenneF,RazaziK,MoutereauS,AbidS,Brun-BuissonC,etal.Adiagnosticnomogramfordelayedhemolytictransfusionreactioninsicklecelldisease.AmJHematol.2016Dec.91(12):1181-1184.[Medline].[FullText]. DelaneyM,WendelS,BercovitzRS,CidJ,CohnC,DunbarNM,etal.Transfusionreactions:prevention,diagnosis,andtreatment.Lancet.2016Dec3.388(10061):2825-2836.[Medline]. Noizat-PirenneF,HabibiA,Mekontso-DessapA,RazaziK,ChadebechP,MahevasM,etal.Theuseofrituximabtopreventseveredelayedhaemolytictransfusionreactioninimmunizedpatientswithsicklecelldisease.VoxSang.2015Apr.108(3):262-7.[Medline]. BluemleLWJr.Hemolytictransfusionreactionscausingacuterenalfailure.Serologicandclinicalconsiderations.PostgradMed.1965Nov.38(5):484-9.[Medline]. TinegateH,BirchallJ,GrayA,HaggasR,MasseyE,NorfolkD,etal.GuidelineontheinvestigationandmanagementofacutetransfusionreactionsPreparedbytheBCSHBloodTransfusionTaskForce.BrJHaematol.2012Oct.159(2):143-53.[Medline]. [Guideline]ClinicalGuidetoTransfusionMedicine:AdverseReactions.CanadianBloodServices.Availableathttps://professionaleducation.blood.ca/en/adverse-reactions.Accessed:January12,2021. DavenportRD.Managementoftransfusionreactions.MintzPD,ed.TransfusionTherapy:ClinicalPrinciplesandPractice.3rded.Bethesda,Md:AmericanAssociationofBloodBanksPress;2010.757-84. MediaGallery Rapidtesttodistinguishhematuriafromhemoglobinuria.Theonsetofredurineduringorshortlyafterabloodtransfusionmayrepresenthemoglobinuria(indicatinganacutehemolyticreaction)orhematuria(indicatingbleedinginthelowerurinarytract).Iffreshlycollectedurinefromapatientwithhematuriaiscentrifuged,redbloodcellssettleatthebottomofthetube,leavingaclearyellowurinesupernatant.Iftheredcolorisduetohemoglobinuria,theurinesampleremainsclearredaftercentrifugation. of 1 Tables BacktoList ContributorInformationandDisclosures Author SGeraldSandler,MD,FCAP,FACP ProfessorEmeritusofMedicineandPathology,GeorgetownUniversitySchoolofMedicine SGeraldSandler,MD,FCAP,FACPisamemberofthefollowingmedicalsocieties:AmericanAssociationofBloodBanks,CollegeofAmericanPathologists,InternationalSocietyofBloodTransfusionDisclosure:Nothingtodisclose. Coauthor(s) VivianaVJohnson,MD MedicalDirector,BloodBank,NavalMedicalCenter,Portsmouth VivianaVJohnson,MDisamemberofthefollowingmedicalsocieties:AmericanAssociationofBloodBanks,CollegeofAmericanPathologistsDisclosure:Nothingtodisclose. SpecialtyEditorBoard FranciscoTalavera,PharmD,PhD AdjunctAssistantProfessor,UniversityofNebraskaMedicalCenterCollegeofPharmacy;Editor-in-Chief,MedscapeDrugReferenceDisclosure:ReceivedsalaryfromMedscapeforemployment.for:Medscape. RonaldASacher,MBBCh,FRCPC,DTM&H ProfessorofInternalMedicineandPathology,Director,HoxworthBloodCenter,UniversityofCincinnatiAcademicHealthCenter RonaldASacher,MBBCh,FRCPC,DTM&Hisamemberofthefollowingmedicalsocieties:AmericanAssociationfortheAdvancementofScience,AmericanAssociationofBloodBanks,AmericanClinicalandClimatologicalAssociation,AmericanSocietyforClinicalPathology,AmericanSocietyofHematology,CollegeofAmericanPathologists,InternationalSocietyofBloodTransfusion,InternationalSocietyonThrombosisandHaemostasis,RoyalCollegeofPhysiciansandSurgeonsofCanadaDisclosure:Nothingtodisclose. ChiefEditor EmmanuelCBesa,MD ProfessorEmeritus,DepartmentofMedicine,DivisionofHematologicMalignanciesandHematopoieticStemCellTransplantation,KimmelCancerCenter,JeffersonMedicalCollegeofThomasJeffersonUniversity EmmanuelCBesa,MDisamemberofthefollowingmedicalsocieties:AmericanAssociationforCancerEducation,AmericanSocietyofClinicalOncology,AmericanCollegeofClinicalPharmacology,AmericanFederationforMedicalResearch,AmericanSocietyofHematology,NewYorkAcademyofSciencesDisclosure:Nothingtodisclose. AdditionalContributors PradyumnaDPhatak,MBBS,MD Chair,DivisionofHematologyandMedicalOncology,RochesterGeneralHospital;ClinicalProfessorofOncology,RoswellParkCancerInstitute PradyumnaDPhatak,MBBS,MDisamemberofthefollowingmedicalsocieties:AmericanSocietyofHematologyDisclosure:ReceivedhonorariafromNovartisforspeakingandteaching. Acknowledgements TheviewsexpressedinthisarticlearethoseoftheauthorsanddonotnecessarilyreflecttheofficialpolicyorpositionoftheDepartmentoftheNavy,DepartmentofDefense,northeU.S.Government. FindUsOn About AboutMedscape PrivacyPolicy EditorialPolicy Cookies DoNotSellMyPersonalInformation TermsofUse AdvertisingPolicy HelpCenter Membership BecomeaMember AboutYou ProfessionalInformation Newsletters&Alerts App Medscape WebMDNetwork MedscapeLiveEvents WebMD MedicineNet eMedicineHealth RxList WebMDCorporate Editions English Deutsch Español Français Português Allmaterialonthiswebsiteisprotectedbycopyright,Copyright©1994-2022byWebMDLLC.Thiswebsitealsocontainsmaterialcopyrightedby3rdparties. Close
延伸文章資訊
- 1輸血相關之急性肺損傷 - 內科醫學會
81. Mair DC, Hirschler N, Eastlund T. Blood donor and component management strategies to prevent ...
- 2TRALI • LITFL • CCC Airway
Transfusion related acute lung injury (TRALI) is defined as hypoxia and bilateral pulmonary edema...
- 3Transfusion-related acute lung injury (TRALI) - Canadian ...
The role of the TMRG is to determine donor management in order to ensure that donors who may repr...
- 4Transfusion-related acute lung injury - Wikipedia
Transfusion-related acute lung injury (TRALI) is the serious complication of transfusion of blood...
- 5TRANSFUSION RELATED ACUTE LUNG INJURY (TRALI)
subsequent management of implicated donors. ... TRALI is a serious complication of blood transfus...